ArticleMolecular oncology2026

In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.

Farhan Ul Haq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.